Gilead Sciences, Inc. vs Marvell Technology, Inc.
μκ°μ λ°λ₯Έ μκ°μ΄μ‘ λΉκ΅
Gilead Sciences, Inc.
$193.5B
μμ #81
Marvell Technology, Inc.
$200.4B
μμ #77
μκ°μ λ°λ₯Έ μκ°μ΄μ‘
μ£Όμ μκ°
- Gilead Sciences, Inc.μ΄(κ°) 2002λ κΉμ§ Marvell Technology, Inc.μ(λ₯Ό) μΆμνμ΅λλ€
- Marvell Technology, Inc.μ΄(κ°) 2003λ κΉμ§ Gilead Sciences, Inc.μ(λ₯Ό) μΆμνμ΅λλ€
- Gilead Sciences, Inc.μ΄(κ°) 2007λ κΉμ§ Marvell Technology, Inc.μ(λ₯Ό) μΆμνμ΅λλ€
- Marvell Technology, Inc.μ΄(κ°) 2026λ κΉμ§ Gilead Sciences, Inc.μ(λ₯Ό) μΆμνμ΅λλ€
μ°λλ³ λΉκ΅
| μ°λ | Gilead Sciences, Inc. | Marvell Technology, Inc. | μ λ |
|---|---|---|---|
| 2026 | $193.5B | $200.4B | Marvell Technology, Inc. |
| 2025 | $150.5B | $74.2B | Gilead Sciences, Inc. |
| 2024 | $110.0B | $96.2B | Gilead Sciences, Inc. |
| 2023 | $92.6B | $52.3B | Gilead Sciences, Inc. |
| 2022 | $94.6B | $32.0B | Gilead Sciences, Inc. |
| 2021 | $76.4B | $75.2B | Gilead Sciences, Inc. |
| 2020 | $58.7B | $40.7B | Gilead Sciences, Inc. |
| 2019 | $63.0B | $22.6B | Gilead Sciences, Inc. |
| 2018 | $58.5B | $13.6B | Gilead Sciences, Inc. |
| 2017 | $65.0B | $17.8B | Gilead Sciences, Inc. |
| 2016 | $63.2B | $11.3B | Gilead Sciences, Inc. |
| 2015 | $87.4B | $7.0B | Gilead Sciences, Inc. |
| 2014 | $80.8B | $11.4B | Gilead Sciences, Inc. |
| 2013 | $64.4B | $11.1B | Gilead Sciences, Inc. |
| 2012 | $31.5B | $5.5B | Gilead Sciences, Inc. |
| 2011 | $17.6B | $10.3B | Gilead Sciences, Inc. |
| 2010 | $15.5B | $13.8B | Gilead Sciences, Inc. |
| 2009 | $18.6B | $15.5B | Gilead Sciences, Inc. |
| 2008 | $21.9B | $5.0B | Gilead Sciences, Inc. |
| 2007 | $19.7B | $10.4B | Gilead Sciences, Inc. |
| 2006 | $13.9B | $14.3B | Marvell Technology, Inc. |
| 2005 | $11.3B | $20.9B | Marvell Technology, Inc. |
| 2004 | $7.5B | $13.2B | Marvell Technology, Inc. |
| 2003 | $6.2B | $7.1B | Marvell Technology, Inc. |
| 2002 | $3.6B | $3.5B | Gilead Sciences, Inc. |
| 2001 | $3.5B | $6.7B | Marvell Technology, Inc. |
| 2000 | $2.2B | $4.1B | Marvell Technology, Inc. |